retatrutide efficacy Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide vs Tirzepatide vs Semaglutide:

While some symptoms overlap with normal injection site reactions, certain indicators suggest the medication may have been delivered into muscle rather than subcutaneous tissue

Retatrutide Phase 2 trial New England Journal of Medicine Peer-reviewed Phase 2 trial data on retatrutide in adults with obesity

The relevance of optimised incretin therapies extends beyond their action on blood glucose regulation and control of body weight, with GLP-1RAs providing beneficial effects for blood pressure disorders (Martins et al., 2020) and neurodegenerative conditions including Alzheimers ( Statements Author contributions All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication

Diabetes 47 , 6631670 (1998)

Therapeutic targeting of microRNAs: current status and future challenges